Mammalian STE20‑like kinase 1 regulates pancreatic cancer cell survival and migration through Mfn2‑mediated mitophagy

Yongli Hu, Bing Wang, Lie Wang, Zhenran Wang, Zhiyuan Jian, Linhong DengMolecular 2020 · DOI · OpenAlex

Note: This paper has been marked with a "RETRACTED" watermark across all pages. The following summary describes the scientific claims made in the original text, but readers should be aware that the validity of these findings has been officially questioned by the publisher.

Abstract

Mammalian STE20-like kinase 1 (MST1) is a known tumor suppressor, yet its specific targets in pancreatic cancer have remained elusive. This study demonstrates that MST1 expression is significantly downregulated in pancreatic cancer cell lines (PANC-1, BxPC-3, and HPAC) compared to normal ductal epithelial cells. Overexpression of MST1 in PANC-1 cells triggers apoptosis and inhibits migration. Mechanistically, MST1 disrupts mitofusin 2 (Mfn2)-mediated mitophagy, leading to mitochondrial dysfunction and decreased ATP production. These findings suggest that the MST1/Mfn2 axis is a critical regulator of pancreatic cancer progression and a potential therapeutic target.

Introduction

Pancreatic cancer is characterized by high mortality and resistance to conventional therapies. The ability of cancer cells to evade apoptosis and metastasize is central to its progression. MST1, a core component of the Hippo signaling pathway, often acts as a tumor suppressor. However, its role in regulating mitochondrial quality control—specifically mitophagy—in pancreatic cancer cells is not well understood. Mitophagy is a survival mechanism where cells degrade damaged mitochondria; inhibiting this process can lead to metabolic catastrophe and cell death.

Methods

The study compared MST1 levels in human pancreatic cancer cell lines (PANC-1, BxPC-3, HPAC) and a normal control line (hTERT-HPNE). PANC-1 cells were transfected with an adenovirus vector to overexpress MST1 (ad-MST1). Researchers assessed cell viability (MTT), apoptosis (TUNEL, Caspase activity), and migration (Wound healing, Transwell assays). Mitochondrial health was evaluated by measuring ATP content, membrane potential, and mPTP opening. Protein expression was analyzed via Western blotting and RT-qPCR.

Results

MST1 Downregulation and Apoptosis Induction

Initial experiments confirmed that MST1 expression is markedly lower in pancreatic cancer cells than in normal pancreatic tissue. Restoring MST1 levels in PANC-1 cells significantly reduced cell viability and increased apoptosis, as evidenced by elevated Caspase-3 activity and a higher percentage of TUNEL-positive cells.

Figure 1: MST1 expression levels in pancreatic cancer cell lines and the effects of MST1 overexpression on PANC-1 cell apoptosis.

Mitochondrial Dysfunction

MST1 overexpression led to a significant decrease in ATP production and a collapse of the mitochondrial membrane potential. This was accompanied by an increased rate of mitochondrial permeability transition pore (mPTP) opening and the activation of the mitochondrial-dependent apoptotic pathway, characterized by increased Bax and decreased Bcl2 expression.

Inhibition of Cell Migration and EMT

Beyond survival, MST1 significantly impaired the migratory capacity of PANC-1 cells. Wound healing and Transwell assays showed a dramatic reduction in cell movement following MST1 overexpression. This was linked to a reversal of the epithelial-to-mesenchymal transition (EMT), with an increase in the epithelial marker E-cadherin and a decrease in mesenchymal markers N-cadherin and Snail.

Discussion

The study identifies MST1 as a potent inhibitor of pancreatic cancer progression. By targeting Mfn2-mediated mitophagy, MST1 prevents cancer cells from maintaining a healthy mitochondrial pool, leading to energy depletion and programmed cell death. Furthermore, the suppression of EMT markers suggests that MST1 may also limit the metastatic potential of these tumors. While these in vitro findings are promising, the official retraction of the original paper necessitates caution in interpreting these results. Future research should focus on validating these mechanisms in vivo and exploring the clinical potential of targeting the MST1/Mfn2 pathway.

Conclusion

MST1 regulates pancreatic cancer cell survival and migration by disrupting mitochondrial homeostasis. Restoring MST1 activity could represent a novel strategy for inducing apoptosis and preventing metastasis in pancreatic cancer.

Summary updated

Abstract

Mammalian STE20-like kinase 1 (MST1) plays an important role in pancreatic cancer progression, but its downstream targets are still unknown. In the present study, our results indicated that MST1 expression was significantly downregulated in pancreatic cancer cell lines (PANC‑1, BxPC‑3 and HPAC) compared with that in the normal ductal epithelial cell line (hTERT‑HPNE). Moreover, MST1 overexpression in PANC‑1 cells led to increased apoptosis as determined by MTT and TUNEL assays and inhibited cellular migration. Mechanistically, upregulation of MST1 expression caused mitochondrial dysfunction, decreased ATP production, and activation of the mitochondrial‑dependent apoptotic pathway via inhibition of mitofusin 2 (Mfn2)‑mediated mitophagy, which ultimately resulted in increased cellular apoptosis and decreased cellular migration. Collectively, the present study demonstrated that MST1 may regulate pancreatic cancer PANC‑1 cell survival, invasion and migration through Mfn2‑mediated mitophagy, laying the foundation for the exploration of novel therapeutic targets for pancreatic cancer.
BibTeX
@inproceedings{hu2020mammalian,
  author = {Yongli Hu and Bing Wang and Lie Wang and Zhenran Wang and Zhiyuan Jian and Linhong Deng},
  title = {{Mammalian STE20‑like kinase 1 regulates pancreatic cancer cell survival and migration through Mfn2‑mediated mitophagy}},
  booktitle = {Molecular},
  year = {2020},
  doi = {10.3892/mmr.2020.11098},
}
Figure